Results 161 to 170 of about 28,792 (217)
Some of the next articles are maybe not open access.

AMODIAQUINE AGRANULOCYTOSIS

Medical Journal of Australia, 1977
A case of profound neutropenia and severe infection after the administration of amodiaquine is presented. The recommended dose for malaria prophylaxis was administered.
P, Gillespie, F, Wagner
openaire   +2 more sources

Isotretinoin‐Induced Agranulocytosis

Pediatric Dermatology, 2007
Abstract:  Isotretinoin is used to treat a spectrum of dermatologic conditions. The present article reports the case of a 15‐year‐old female patient who exhibited agranulocytosis after the initiation of isotretinoin administration. Agranulocytosis is a rare but life‐threatening side effect of isotretinoin use, and clinicians must be aware of ...
Patiroglu, Türkan   +5 more
openaire   +3 more sources

Agranulocytosis

Annals of Internal Medicine, 1930
The red marrow of the bones makes erythrocytes, granular leukocytes and platelets. In agranulocytosis, the factory that makes the granulocytes has shut down. The life of this cell in the normal conditions of health is three days or more,1and from three to five days by other evidences.
STEWART R. ROBERTS, ROY R. KRACKE
openaire   +2 more sources

Drug-induced Agranulocytosis

Clinics in Haematology, 1980
Drug-induced agranulocytosis is relatively rare. It is a heterogeneous disorder in pathogenetic terms, not surprisingly in view of its idosyncratic nature. Indeed, one drug might cause agranulocytosis by different mechanisms in different patients. Recent investigations suggest that there are at least three mechanisms by which it can be produced, namely
G A, Young, P C, Vincent
openaire   +2 more sources

PENICILLIN IN AGRANULOCYTOSIS

Journal of the American Medical Association, 1946
To the Editor:— Our recent experience with penicillin in the treatment of thiouracil induced agranulocytosis has created in our minds a point of view at variance with the report of the Council on Pharmacy and Chemistry of February 9. We are referring to the recommendation that a daily dosage of 500,000 units is the desirable method of treatment in ...
M G, VORHAUS, H H, ROTHENDLER
openaire   +2 more sources

Propafenone Associated Agranulocytosis

Pacing and Clinical Electrophysiology, 1992
Propafenone hydrochloride was approved for marketing by the United States (U.S.) Food and Drug Administration (FDA) in November 1989. During U.S. clinical trials of propafenone, one case of agranulocytosis was seen. Seven additional cases have been reported outside the U.S. One German report of profound but reversible granulocytopenia appeared in 1982.
L J, Miwa, H M, Jolson
openaire   +2 more sources

Drug-Induced Agranulocytosis

Medical Toxicology, 1988
Agranulocytosis is a rare but potentially serious adverse side effect of many drugs. Although it was recognised as an idiosyncratic type of drug reaction more than 50 years ago, its pathogenesis is still not fully understood. Drug-related antibodies are responsible for the neutropenia in the so-called 'immune' or 'aminopyrine' type of agranulocytosis ...
openaire   +2 more sources

Cimetidine agranulocytosis

Medical Journal of Australia, 1981
G A, Young, P C, Vincent
openaire   +2 more sources

Congenital agranulocytosis

The Journal of Pediatrics, 1966
C E, Krill, A M, Mauer
openaire   +2 more sources

Home - About - Disclaimer - Privacy